SCHEMBL19360210

SCHEMBL19360210

Oc1nc(O)c2c(n1)CN1CCCC21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19360207 0.85 — —
SCHEMBL19360218 0.81 CHRNA7 (0.35) —
SCHEMBL19362376 0.80 CYP2D6 (0.30) —
SCHEMBL19360195 0.75 JUN (0.35) —
SCHEMBL19360204 0.74 — —
SCHEMBL19360214 0.72 JUN (0.34) —
SCHEMBL19349909 0.71 JUN (0.35) —
SCHEMBL19349849 0.69 JUN (0.34) —
SCHEMBL19360202 0.66 CHRNA7 (0.43) —
SCHEMBL19360217 0.66 CHRNA7 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170267679-A1 TRICYCLIC FUSED PYRIMIDINE COMPOUNDS AS INHIBITORS OF p97 COMPLEX CLEAVE BIOSCIENCES INC (US) 2017-09-21 — — US disclosed
Send feedback